Universal Technical Institute, Inc. (UTI) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, UTI trades at $36.83 with a market cap of $2.15B and a P/E ratio of 47.19. UTI moved +3.13% today. Year to date, UTI is +35.13%; over the trailing twelve months it is +4.78%. Its 52-week range spans $15.14 to $41.53. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces UTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes UTI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $36.83 |
| Market Cap | $2.15B |
| P/E Ratio | 47.19 |
| EPS | $0.78 |
| Dividend Yield | 0.02% |
| 52-Week High | $41.53 |
| 52-Week Low | $15.14 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $868.99M |
| Net Income | $42.68M |
| Gross Margin | 0.00% |
6 analysts cover UTI: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.00.